Emerson Clinical Research Institute

Why doctors are crucial to increasing minority populations in clinical research

Wednesday, April 1, 2015

In the age of personalized medicine, it seems obvious that a clinical trial studying a new medicine should in­clude representatives from the entire population to whom it may be pre­scribed. However, for many studies currently being conducted, this is not the case. While globalization has broadened the overall diversity of participation in clinical trials, in the U.S. the patients taking part in trials are not characteristic of the popula­tion at large.

[Read More]